Nov 17, 2025 04:01PM Enanta Pharma (ENTA) Tops Q4 EPS by 14c

Nov 14, 2025 02:39AM JPMorgan Starts Enanta Pharmaceuticals (ENTA) at Overweight

Oct 20, 2025 07:00AM Enanta presents new RSV drug data at IDWeek 2025 conference

Oct 1, 2025 10:52AM Jefferies Upgrades Enanta Pharmaceuticals (ENTA) to Buy

Sep 30, 2025 04:40PM After-hours movers: Nike, Morgan Stanley, Marvell Technology and more

Sep 30, 2025 06:53AM H.C. Wainwright Reiterates Buy Rating on Enanta Pharmaceuticals (ENTA)

Sep 30, 2025 04:20AM Enanta Pharmaceuticals (ENTA) PT Raised to $9 at Leerink Partners

Sep 29, 2025 06:30AM Enanta reports positive results from RSV drug trial in high-risk adults

Sep 3, 2025 06:01AM Enanta Pharmaceuticals CFO Paul Mellett passes

Aug 12, 2025 04:15AM Enanta Pharmaceuticals (ENTA) PT Raised to $25 at Citizens JMP

Aug 11, 2025 04:02PM Enanta Pharma (ENTA) Misses Q3 EPS by 1c

Jul 28, 2025 06:58AM H.C. Wainwright Assumes Enanta Pharmaceuticals (ENTA) at Buy

Jun 11, 2025 12:34PM Enanta Pharma's (ENTA) Partner AbbVie Receives U.S. FDA Approval of an Expanded Indication for MAVYRET® (glecaprevir/pibrentasvir) as the First and Only Treatment for People with Acute Hepatitis C Vi

Jun 3, 2025 04:21AM Enanta Pharmaceuticals (ENTA) PT Raised to $24 at Citizens JMP

May 22, 2025 07:02AM Enanta Pharma (ENTA) Announces Data from its Phase 2 Study of Zelicapavir in Children with Respiratory Syncytial Virus to be Presented

May 14, 2025 04:11AM Enanta Pharmaceuticals (ENTA) PT Raised to $23 at Citizens JMP

May 12, 2025 04:03PM Enanta Pharma (ENTA) Tops Q2 EPS by 10c, Misses on Revenue

Feb 11, 2025 06:47AM H.C. Wainwright Reiterates Buy Rating on Enanta Pharmaceuticals (ENTA)

Feb 11, 2025 04:18AM JMP Securities Reiterates Market Outperform Rating on Enanta Pharmaceuticals (ENTA)

Feb 10, 2025 04:01PM Enanta Pharma (ENTA) Tops Q1 EPS by 22c

Dec 24, 2024 07:00AM Enanta Pharma (ENTA) to Appeal Ruling Related to ‘953 Patent Infringement Lawsuit

Dec 24, 2024 06:50AM Enanta Pharmaceuticals (ENTA) PT Lowered to $18 at H.C. Wainwright

Dec 9, 2024 06:32AM Enanta Pharma (ENTA) Announces Positive Topline Results from First-in-Pediatrics Phase 2 Study

Nov 26, 2024 02:45PM Enanta Pharmaceuticals (ENTA) PT Raised to $12 at Leerink Partners

Nov 26, 2024 06:40AM Enanta Pharmaceuticals (ENTA) PT Lowered to $20 at Baird

Nov 25, 2024 04:02PM Enanta Pharma (ENTA) Misses Q4 EPS by 20c

Oct 10, 2024 06:57AM H.C. Wainwright Reiterates Buy Rating on Enanta Pharmaceuticals (ENTA)

Oct 9, 2024 08:49AM JMP Securities Reiterates Market Outperform Rating on Enanta Pharmaceuticals (ENTA)

Sep 27, 2024 06:56AM Baird Reiterates Outperform Rating on Enanta Pharmaceuticals (ENTA)

Sep 26, 2024 06:02AM Enanta Pharma (ENTA) Reports Positive Topline Results for EDP-323

Aug 5, 2024 04:39PM Enanta Pharma (ENTA) Tops Q3 EPS by 36c